Adult height prediction by bone age determination in children with isolated growth hormone deficiency

Thomas Reinehr1, Martin Carlsson2, Dionisios Chrysis3

  • 1Pediatric Endocrinology, Diabetes and Nutrition Medicine, Vestische Children's Hospital, University of Witten/Herdecke, Datteln, Germany.

Endocrine Connections
|April 9, 2020
PubMed

Insights

Adult height prediction in children with idiopathic growth hormone deficiency (IGHD) using bone age methods like Bayley-Pinneau (BP) and Tanner-Whitehouse 2 (TW2) initially underestimates final height. Over time, these methods overestimate adult height in IGHD patients.

Area of Science:

  • Pediatric Endocrinology
  • Growth Disorders
  • Medical Statistics

Background:

  • Assessing the accuracy of adult height prediction is crucial for managing children with idiopathic growth hormone deficiency (IGHD).
  • The precision of bone age determination methods for predicting final height in IGHD patients remains unclear.

Purpose of the Study:

  • To evaluate the accuracy of adult height prediction using the Bayley-Pinneau (BP) and Tanner-Whitehouse 2 (TW2) methods in children with IGHD.
  • To compare the predictive accuracy of these methods at different stages of growth hormone (GH) treatment.

Main Methods:

  • Retrospective analysis of near adult height (NAH) from the KIGS database for patients with IGHD.
  • Comparison of NAH with adult height predictions derived from bone age assessments using BP (Greulich-Pyle) and TW2 methods.
  • Statistical analysis using multiple linear regression, adjusting for key treatment and patient variables.

Main Results:

  • Both BP and TW2 methods significantly underestimated adult height at baseline in IGHD patients.
  • Prediction accuracy improved after one year of GH treatment, with BP showing less underestimation than TW2.
  • By the final bone age assessment, both methods overestimated adult height, with BP overestimating more in boys and TW2 overestimating in both sexes.

Conclusions:

  • Height prediction by BP and TW2 methods underestimates adult height in prepubertal IGHD children at the onset of GH treatment.
  • After approximately 6 years of GH treatment, these prediction methods tend to overestimate adult height in IGHD patients.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.0K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
3.3K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.2K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.9K